|
Volumn 437, Issue 1-2, 2012, Pages 275-276
|
Cyclosporin nanosphere formulation for ophthalmic administration
|
Author keywords
Cyclosporin A; Dry eye disease; Nanosphere; Pro dispersion
|
Indexed keywords
CYCLOSPORIN A;
NANOSPHERE;
ANIMAL EXPERIMENT;
ARTICLE;
CONTROLLED STUDY;
DISPERSION;
DRUG BIOAVAILABILITY;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG PENETRATION;
DRY EYE;
EMULSION;
EXPERIMENTAL RABBIT;
EYE IRRITATION;
EYELID REFLEX;
NONHUMAN;
OSMOLARITY;
PARTICLE SIZE;
PH;
PRIORITY JOURNAL;
ADMINISTRATION, OPHTHALMIC;
ANIMALS;
ANTI-INFLAMMATORY AGENTS;
CYCLOSPORINE;
EYE;
GLYCEROL;
HEXOSES;
LECITHINS;
NANOSPHERES;
PHARMACEUTICAL VEHICLES;
POLYSORBATES;
PROPYLENE GLYCOL;
RABBITS;
SOLVENTS;
SURFACE-ACTIVE AGENTS;
TRIGLYCERIDES;
|
EID: 84866733031
PISSN: 03785173
EISSN: 18733476
Source Type: Journal
DOI: 10.1016/j.ijpharm.2012.08.016 Document Type: Article |
Times cited : (23)
|
References (9)
|